DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Orchid Pharma Limited — Shareholders meeting

NSE 1 hr ago·29 Sept 2026, 1:12 pm

Orchid Pharma

Orchid Pharma Limited has informed the stock exchanges that its 33rd Annual General Meeting (AGM) was successfully held on September 29, 2026. During this meeting, the company’s directors approved the financial results for the previous fiscal year and adopted the necessary resolutions for the upcoming period.

For investors, this update confirms that the company is in compliance with regulatory requirements and has completed its standard governance procedures. While the AGM itself does not typically announce new business strategies, it serves as a formal confirmation of the company's operational status and financial standing.

Investors should look for the detailed audited financial statements and management commentary released alongside this announcement to gauge the company's performance and future outlook.